Skip to content

Multicenter study to evaluate glaucoma detection ability by new visual field test program (SITA Standard 24-2C)

Multicenter study to evaluate glaucoma detection ability by new visual field test program (SITA Standard 24-2C)

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCTs032210411
Enrollment
50
Registered
2021-11-05
Start date
2022-12-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glaucoma or suspected glaucoma

Interventions

1) Basic data determination, explanatory consent, and registration in regular medical treatment before entry (visit 1) Confirmation of the background of the research subject, subjective symptoms and o
visit 3) Subjective symptoms and other findings, normal glaucoma examination (visual acuity, intraocular pressure, etc.), visual field test, and SITA Standard 24-2C, SITA Faster 24-2C, and SITA Standa

Sponsors

Nakano Tadashi
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Patients with glaucoma or suspected glaucoma on regular visits to the hospital 2) Patients with or without treatment. 3) Patients who have previously undergone HFA visual field testing (SITA Standard 24-2 program) and have an MD of -25D or higher and corrected visual acuity of 0.5 or higher (4) Age: Those who are 20 years old or older at the time of obtaining consent. 5) Gender: Any. (6) Those who have received sufficient explanations about participation in this study, and have given written consent of their own free will with sufficient understanding. (7) Those who are able to attend outpatient clinics according to the research implementation schedule

Exclusion criteria

Exclusion criteria: 1) Patients who did not give consent to participate in this study 2) Eyes with ocular findings that affect the visual field other than glaucoma, or eyes that have previously undergone internal eye surgery other than cataract or glaucoma 3) Other patients who are judged by the principal investigator to be inappropriate for participation in this study.

Design outcomes

Primary

MeasureTime frame
The sensitivity thresholds, the occurrence rate of anomaly probability plots, and the Mean Deviation values for the entire visual field at each measurement point obtained by the SITA Standard 24-2C program will be examined.The comparison programs will be SITA Faster 24-2C, SITA Standard 24-2, and 10-2.

Secondary

MeasureTime frame
1) Examine the inspection time for each program Evaluate the inspection time of the new program and examine the validity of the added inspection points. 2) Examination of the correspondence between structure and function Optical coherence tomography (OCT) and stereoscopic fundus photography will be performed in conjunction, and the validity of the detected visual field abnormalities (abnormalities in function) will be evaluated by comparing them with structural changes in the retina.

Contacts

Public ContactTakahiko Noro

The Jikei University Hospital

ta-noro@pg8.so-net.ne.jp+81-3-3433-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026